229 related articles for article (PubMed ID: 19221617)
1. Long-term benefits of specific immunotherapy (SIT).
Olaguibel JM
Drugs Today (Barc); 2008 Dec; 44 Suppl B():39-41. PubMed ID: 19221617
[No Abstract] [Full Text] [Related]
2. Meta-analyses of specific immunotherapy trials.
Calderon MA
Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
[No Abstract] [Full Text] [Related]
3. Preventive effects of sublingual immunotherapy.
Passalacqua G
Drugs Today (Barc); 2008 Dec; 44 Suppl B():83-6. PubMed ID: 19221627
[No Abstract] [Full Text] [Related]
4. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
[TBL] [Abstract][Full Text] [Related]
5. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
Pfaar O; Hörmann K; Klimek L
MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
[TBL] [Abstract][Full Text] [Related]
6. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
Wolthers OD; Høst A; Frederiksen B; Halken S
Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
[TBL] [Abstract][Full Text] [Related]
7. [Allergen specific immunotherapy: new approaches].
Tay F; Kündig TM; Senti G
Praxis (Bern 1994); 2010 Oct; 99(21):1279-84. PubMed ID: 20960398
[TBL] [Abstract][Full Text] [Related]
8. [Cluster immunotherapy in allergic rhinoconjunctivitis].
Klimek L; Pfaar O
MMW Fortschr Med; 2011 Feb; 153(7):34-6. PubMed ID: 21648138
[No Abstract] [Full Text] [Related]
9. [Allergen-specific immunotherapy in allergic rhinitis].
Klimek L; Grevers G
MMW Fortschr Med; 2008 Feb; 150(9):29-33; quiz 34. PubMed ID: 18402267
[No Abstract] [Full Text] [Related]
10. Steroids vs immunotherapy for allergic rhinitis - out with the old, in with the new.
Aasbjerg K; Backer V
Expert Rev Clin Immunol; 2014 Feb; 10(2):171-3. PubMed ID: 24410534
[TBL] [Abstract][Full Text] [Related]
11. Immunological investigation and treatment of rhinitis and bronchial asthma.
Sharp A
Aust Fam Physician; 1985 Jun; 14(6):489-97. PubMed ID: 4026698
[No Abstract] [Full Text] [Related]
12. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.
Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; Carlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T
Allergy; 2011 Jun; 66(6):765-74. PubMed ID: 21496059
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous versus sublingual immunotherapy.
Lin CH; Alandijani S; Lockey RF
Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
[No Abstract] [Full Text] [Related]
14. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.
Jacobsen L; Niggemann B; Dreborg S; Ferdousi HA; Halken S; Høst A; Koivikko A; Norberg LA; Valovirta E; Wahn U; Möller C;
Allergy; 2007 Aug; 62(8):943-8. PubMed ID: 17620073
[TBL] [Abstract][Full Text] [Related]
15. [Vaccination with allergens in children].
Demoly P; Dhivert-Donnadieu H; Bousquet J
Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy.
Harmanci K; Razi CH; Toyran M; Kanmaz G; Cengizlier MR
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):7-13. PubMed ID: 20527510
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
Bahceciler NN; Cobanoglu N
Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in specific immunotherapy for allergic rhinitis.
Bousquet J; Hejjaoui A; Michel FB
Clin Exp Allergy; 1991 Jan; 21 Suppl 1():259-61. PubMed ID: 2032157
[No Abstract] [Full Text] [Related]
19. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
Fuchs T; Klimek L
HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067
[No Abstract] [Full Text] [Related]
20. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy.
Czarnecka-Operacz M; Jenerowicz D; Silny W
Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
